These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3309758)

  • 1. Assay of the cell-mediated immunity in patients with malignant and non-malignant diseases.
    Coeugniet EG
    Onkologie; 1987 Jun; 10(3 Suppl):22-6. PubMed ID: 3309758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation with Viscum album and Echinacea purpurea extracts.
    Coeugniet EG; Elek E
    Onkologie; 1987 Jun; 10(3 Suppl):27-33. PubMed ID: 3309759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high-dose inhaled fluticasone propionate via spacer on cell-mediated immunity in healthy volunteers.
    Sharma KC; Stevens D; Casey L; Kesten S
    Chest; 2000 Oct; 118(4):1042-8. PubMed ID: 11035675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.
    Nemoto T; Han T; Minowada J; Angkur V; Chamberlain A; Dao L
    J Natl Cancer Inst; 1974 Sep; 53(3):641-5. PubMed ID: 4606319
    [No Abstract]   [Full Text] [Related]  

  • 5. Demonstration of cell-mediated and humoral antibodies in patients with malignant breast and ovary-tumours.
    Kitschke HJ; Krebs D
    Acta Eur Fertil; 1973 Jun; 4(2):75-7. PubMed ID: 4784141
    [No Abstract]   [Full Text] [Related]  

  • 6. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
    van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
    Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte stimulation by phytohemagglutinin and tumor cells of malignant effusions.
    Robinson E; Sher S; Mekori T
    Cancer Res; 1974 Jul; 34(7):1548-51. PubMed ID: 4275697
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell-mediated immunity in the rheumatoid diseases. I. Skin testing and mitogenic responses in sero-negative arthritides.
    Froebel K; Sturrock RD; Dick WC; MacSween RN
    Clin Exp Immunol; 1975 Dec; 22(3):446-52. PubMed ID: 1083785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of immune monitoring in gynecologic cancer patients receiving immunotherapy.
    DiSaia PJ; Rich WM
    Am J Obstet Gynecol; 1979 Dec; 135(7):907-16. PubMed ID: 315714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immunity in psoriatic arthritis.
    Espinoza LR; Gaylord SW; Vasey FB; Osterland CK
    J Rheumatol; 1980; 7(2):218-24. PubMed ID: 6966333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD80-transfected human breast and ovarian tumor cell lines: improved immunogenicity and induction of cytolytic CD8+ T lymphocytes.
    Gückel B; Lindauer M; Rudy W; Habicht A; Siebels M; Kaul S; Bastert G; Meuer SC; Moebius U
    Cytokines Mol Ther; 1995 Sep; 1(3):211-21. PubMed ID: 9384677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic monitoring in carcinoma of the breast.
    Weese JL; Oldham RK; Tormey DC; Barlock AL; Morales A; Cohen MH; West WH; Herberman RB; Alford TC; Shorb PE; Tsangaris NT; Cannon GB; Dean JH; Djeu J; McCoy JL
    Surg Gynecol Obstet; 1977 Aug; 145(2):209-18. PubMed ID: 141745
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunization.
    Disis ML; Schiffman K; Gooley TA; McNeel DG; Rinn K; Knutson KL
    Clin Cancer Res; 2000 Apr; 6(4):1347-50. PubMed ID: 10778962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer.
    Knutson KL; Krco CJ; Erskine CL; Goodman K; Kelemen LE; Wettstein PJ; Low PS; Hartmann LC; Kalli KR
    J Clin Oncol; 2006 Sep; 24(26):4254-61. PubMed ID: 16908932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence.
    Kopersztych S; Rezkallah MT; Miki SS; Naspitz CK; Mendes NF
    Cancer; 1976 Sep; 38(3):1149-54. PubMed ID: 1085193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cellular immunity indices in benign breast tumors].
    Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
    Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immunity in early human breast carcinoma.
    Conesa LC; Pasqualini RS; Pujato D; Lynch M
    Cell Mol Biol Incl Cyto Enzymol; 1979; 24(4):355-61. PubMed ID: 387244
    [No Abstract]   [Full Text] [Related]  

  • 18. [Proceedings: Demonstration of humoral and cellular antibodies in human genital and breast carcinoma].
    Kitschke HJ; Kleinhans V; Stoldt A; Krebs D
    Arch Gynakol; 1973 Sep; 214(1):299-301. PubMed ID: 4801464
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence.
    Mandeville R; Lamoureux G; Legault-Poisson S; Poisson R
    Cancer; 1982 Oct; 50(7):1280-8. PubMed ID: 6980699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of lymphocyte-mediated tumor-cell destruction by certain patient sera.
    Hellström I; Hellström KE; Warner GA
    Int J Cancer; 1973 Sep; 12(2):348-53. PubMed ID: 4792348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.